Cargando…
Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET (A) receptor antagonism
Endothelin-1 (ET-1) is a vasoconstrictor peptide which stimulates proliferation in vitro in different cell types, including colorectal cancer cells. Raised ET-1 levels have been detected both on tissue specimens and in the plasma of patients with cancers. To investigate the role of ET-1 in colorecta...
Autores principales: | Asham, E, Shankar, A, Loizidou, M, Fredericks, S, Miller, K, Boulos, P B, Burnstock, G, Taylor, I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363991/ https://www.ncbi.nlm.nih.gov/pubmed/11742499 http://dx.doi.org/10.1054/bjoc.2001.2193 |
Ejemplares similares
-
Endothelin-1: a multifunctional molecule in cancer
por: Grant, K, et al.
Publicado: (2003) -
Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats
por: Carbó, N, et al.
Publicado: (2000) -
The absence of autonomic perivascular nerves in human colorectal liver metastases.
por: Ashraf, S., et al.
Publicado: (1996) -
Plasma Pro‐Endothelin‐1 Peptide Concentrations Rise in Chronic Kidney Disease and Following Selective Endothelin A Receptor Antagonism
por: Dhaun, Neeraj, et al.
Publicado: (2015) -
Serial troponin measurements to monitor risk and response to endothelin A antagonism in chronic kidney disease
por: Anand, Atul, et al.
Publicado: (2020)